Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy China Pharma stock | $0.43

Own China Pharma stock in just a few minutes.

Fact checked

China Pharma Holdings, Inc is a drug manufacturers-specialty & generic business based in the US. China Pharma shares (CPHI) are listed on the NYSE MKT and all prices are listed in US Dollars. China Pharma employs 228 staff and has a trailing 12-month revenue of around USD$11 million.

How to buy shares in China Pharma

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for China Pharma. Find the stock by name or ticker symbol: CPHI. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until China Pharma reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$0.43, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of China Pharma, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of China Pharma. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

China Pharma share price

Use our graph to track the performance of CPHI stocks over time.

China Pharma shares at a glance

Information last updated 2020-12-27.
Latest market closeUSD$0.43
52-week rangeUSD$0.2275 - USD$1.4
50-day moving average USD$0.4433
200-day moving average USD$0.463
Wall St. target priceUSD$3
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.246

Buy China Pharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Forex
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Public
$0
Stocks, ETFs
N/A
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy China Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

China Pharma price performance over time

Historical closes compared with the close of $0.43 from 2020-12-18

1 week (2021-01-15) -36.76%
1 month (2020-12-23) -8.51%
3 months (2020-10-22) -4.44%
6 months (2020-07-22) -25.73%
1 year (2020-01-22) 2.14%
2 years (2019-01-22) 50.88%
3 years (2018-01-22) 19.44%
5 years (2016-01-22) 207.14%

Is China Pharma under- or over-valued?

Valuing China Pharma stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of China Pharma's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

China Pharma's EBITDA

China Pharma's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$257,212.

The EBITDA is a measure of a China Pharma's overall financial performance and is widely used to measure a its profitability.

China Pharma financials

Revenue TTM USD$11 million
Gross profit TTM USD$1.5 million
Return on assets TTM -6.43%
Return on equity TTM -115.87%
Profit margin -185.76%
Book value $0.18
Market capitalisation USD$19.5 million

TTM: trailing 12 months

Shorting China Pharma shares

There are currently 129,086 China Pharma shares held short by investors – that's known as China Pharma's "short interest". This figure is 28.7% up from 100,308 last month.

There are a few different ways that this level of interest in shorting China Pharma shares can be evaluated.

China Pharma's "short interest ratio" (SIR)

China Pharma's "short interest ratio" (SIR) is the quantity of China Pharma shares currently shorted divided by the average quantity of China Pharma shares traded daily (recently around 806787.5). China Pharma's SIR currently stands at 0.16. In other words for every 100,000 China Pharma shares traded daily on the market, roughly 160 shares are currently held short.

However China Pharma's short interest can also be evaluated against the total number of China Pharma shares, or, against the total number of tradable China Pharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case China Pharma's short interest could be expressed as 0% of the outstanding shares (for every 100,000 China Pharma shares in existence, roughly 0 shares are currently held short) or 0.0053% of the tradable shares (for every 100,000 tradable China Pharma shares, roughly 5 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against China Pharma.

Find out more about how you can short China Pharma stock.

China Pharma share dividends

We're not expecting China Pharma to pay a dividend over the next 12 months.

Have China Pharma's shares ever split?

China Pharma's shares were split on a 1000:21804 basis on 15 August 2003. So if you had owned 21804 shares the day before before the split, the next day you'd have owned 1000 shares. This wouldn't directly have changed the overall worth of your China Pharma shares – just the quantity. However, indirectly, the new 2080.4% higher share price could have impacted the market appetite for China Pharma shares which in turn could have impacted China Pharma's share price.

China Pharma share price volatility

Over the last 12 months, China Pharma's shares have ranged in value from as little as $0.2275 up to $1.4. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while China Pharma's is 0.4845. This would suggest that China Pharma's shares are less volatile than average (for this exchange).

China Pharma overview

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site